Do high triglycerides, low HDL, and low SHBG indicate hepatic insulin resistance?

The biochemical triad of elevated triglycerides, low high-density lipoprotein (HDL) cholesterol, and low sex hormone–binding globulin (SHBG) is a validated metabolic signature reflecting hepatic insulin resistance and underlying non-alcoholic fatty liver changes.

Clinical and effectiveness evidence

The combination of high triglycerides and low HDL—often expressed as the TG/HDL ratio—is a robust surrogate marker for systemic and hepatic insulin resistance.

• Lipid profiling: In states of insulin resistance, the liver overproduces large, triglyceride-rich VLDL particles while HDL levels drop due to accelerated clearance of small, dense particles.
• SHBG as a biomarker: Low SHBG levels independently predict the development of type 2 diabetes and metabolic syndrome. In clinical studies, lower circulating SHBG consistently correlates with increased liver fat content and impaired insulin sensitivity across diverse populations, including young and middle-aged men.

Mechanistic explanations

The dysregulation of these markers is driven by two diverging pathways within the insulin-resistant liver:

• VLDL Overproduction: Impaired insulin signaling fails to suppress the transcription factor FoxO1. This leads to increased expression of microsomal triglyceride transfer protein (MTP), which is essential for assembling VLDL. Simultaneously, "selective" resistance allows the lipogenic SREBP-1c pathway to remain active, fueled by compensatory hyperinsulinemia. This results in a continuous supply of new fatty acids being packaged into VLDL.
• SHBG Suppression: SHBG production is primarily regulated by Hepatocyte Nuclear Factor 4-alpha (HNF4α). In hepatic insulin resistance, high levels of portal insulin and increased de novo lipogenesis (DNL) suppress HNF4α. Specifically, the accumulation of palmitate and other lipids within hepatocytes directly downregulates the SHBG gene, making low SHBG a direct "readout" of a fatty, insulin-resistant liver.

Bottom line

This metabolic pattern reflects a synchronized failure of hepatic insulin signaling where the liver overproduces triglycerides while simultaneously reducing the synthesis of SHBG, serving as a critical early warning sign of metabolic dysfunction.